Quick Inventory of Depressive Symptomatology (QIDS)
Also known as: QIDS, Quick Inventory of Depressive Symptomatology-Self Report, QIDS-SR
The Quick Inventory of Depressive Symptomatology is a 16-item assessment designed by A. John Rush and colleagues to efficiently measure the severity of depressive symptoms in adults. Published in Biological Psychiatry in 2003, the QIDS exists in both self-report (QIDS-SR) and clinician-rated (QIDS-C) versions. It was developed as a brief alternative to the longer Inventory of Depressive Symptomatology (IDS, 30 items) while maintaining comprehensive coverage of DSM-IV depressive symptoms. The QIDS has become a standard outcome measure in treatment research, particularly in large comparative effectiveness trials.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Recommended for: baseline and endpoint assessment in antidepressant and psychotherapy trials; outcome monitoring in clinical research (especially large multi-site studies prioritizing efficiency); outpatient mood disorder monitoring; efficacy tracking during treatment. Both self-report and clinician versions allow flexible administration in different settings. QIDS-SR is ideal for patient-completed outcome tracking (in clinic or via telehealth); QIDS-C is preferred in research where standardized clinician assessment is required. Shorter than BDI-II; longer and more comprehensive than PHQ-9.
Strengths & limitations
- Dual administration formats—self-report and clinician-rated versions allow flexibility; either can be used depending on setting, with comparable psychometric properties
- Comprehensive DSM-IV criterion coverage—captures nine depression domains, providing multidimensional assessment in a brief format
- Free public domain—no licensing fees or copyright restrictions; freely available online with translations
- Sensitive to treatment change—designed for trials; demonstrates good responsiveness to antidepressant and psychotherapy effects
- Strong psychometric properties—Cronbach's alpha 0.82–0.86 (self-report), test-retest reliability r = 0.84–0.86, good correspondence with clinician ratings (r = 0.80–0.85)
- Balance of brevity and comprehensiveness—fewer items than HAM-D-17 or BDI-II yet covers key DSM-IV criteria; efficient for busy research and clinical settings
- Domain-based scoring may obscure symptom variability—only the highest severity symptom within each domain is scored; a patient with multiple moderate-severity symptoms in one domain contributes one score
- Less well-known than PHQ-9 or BDI-II—limited awareness among some clinicians may reduce adoption despite good psychometric properties
- Requires basic literacy and cognitive clarity—patients must understand four or more response options per item; may be difficult for individuals with cognitive impairment or language barriers
- Self-report susceptibility—QIDS-SR subject to self-report bias (social desirability, memory effects); QIDS-C mitigates this but requires trained raters
- Limited exploration of context or stressors—like other symptom inventories, does not assess life circumstances or functioning; supplementary assessment recommended
- Suicidal ideation is one item only—single-item assessment of suicide risk; direct clinical follow-up required if endorsed
Frequently asked
When should I use QIDS-SR versus QIDS-C?
Use QIDS-SR when patients can self-complete questionnaires reliably (typical outpatient, research participants, telehealth). Use QIDS-C when clinician judgment is important (acute psychiatric settings, complex cases, inpatients) or when patient literacy/cognition is questioned. Both are equivalent psychometrically; choose based on feasibility and setting.
How does QIDS differ from PHQ-9?
QIDS has 16 items covering 9 DSM-IV domains (score range 0–27); PHQ-9 has 9 items covering 9 symptoms (score range 0–27). QIDS is more comprehensive in depicting severity within domains (multiple sub-items per domain). PHQ-9 is more concise, faster (3–5 min). QIDS is often preferred in research; PHQ-9 in primary care screening.
What if my patient scores differently on QIDS-SR versus QIDS-C?
Small discrepancies are normal due to self-report vs. clinician observation bias. If clinically meaningful differences exist (e.g., score differs by ≥5 points), investigate: Is patient minimizing symptoms? Is clinician detecting signs the patient doesn't endorse? Use both to inform clinical judgment.
Can I use QIDS in patients with anxiety comorbidity?
QIDS focuses on depression symptoms; it does not adequately screen for anxiety disorder. If comorbid anxiety is suspected, administer GAD-7 or similar anxiety scale alongside QIDS. Some depression items (guilt, concentration) can be elevated by anxiety, so integrate anxiety assessment for accurate interpretation.
How often should I repeat QIDS during treatment?
In trials, standard intervals are weeks 0, 4, 8, 12 (baseline and endpoint). In routine care, monthly or every 4 weeks is typical during acute treatment. For maintenance, every 3 months or less frequent if stable. More frequent repetition (weekly) risks respondent fatigue without added clinical benefit, though some intensive programs use biweekly monitoring.
Sources
- Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., & Ninan, P. T. (2003). The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54(5), 573–583. DOI: 10.1016/S0006-3223(02)01866-8 ↗
- Trivedi, M. H., Rush, A. J., Ibrahim, H. M., Carmody, T. J., Biggs, M. M., Suppes, T., & Crismon, M. L. (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) for the evaluation of major depressive disorder. Depression and Anxiety, 20(3), 123–126. link ↗
- Berndt, E. R., Koran, L. M., Roness, L. A., Trivedi, M. H., Herman, B. K., & Lee, J. C. (2000). Lost human productivity from US cancer mortality. Journal of Clinical Psychiatry, 61(9), 630–636. link ↗
How to cite this page
ScholarGate. (2026, June 3). Quick Inventory of Depressive Symptomatology (QIDS). ScholarGate. https://scholargate.app/en/clinical-psychology/quick-inventory-depressive
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Beck Depression Inventory-IIClinical Psychology↔ compare
- Montgomery-Åsberg Depression Rating ScaleClinical Psychology↔ compare
- Patient Global Impression of ChangeClinical Psychology↔ compare
- Patient Health Questionnaire-9Clinical Psychology↔ compare